Urologia, S.C.

















  • Maffezzini M. High-Risk Prostate Cancer is Worth Further Risk Stratification. Eur Urol. 2007 Nov 2
  • Maffezzini M, Campodonico F, Canepa G, Gerbi G, Parodi D. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus. Surg Oncol. 2007 Oct 23. [Epub ahead of print]
  • Maffezzini M. The survival of patients with bone metastases from renal cell carcinoma. Eur Urol. 2007 Jul;52(1):169
  • Maffezzini M, Gerbi G, Campodonico F, Parodi D. Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications. Urology. 2007 Jun; 69(6):1107-11
  • Campodonico F, Mattioli F, Manfredi V, Capponi G, Pasquini P, Martelli A, Maffezzini M. Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.  Anticancer Res. 2007 Mar-Apr;27(2):1179-83
  • Maffezzini M, Bossi A, Collette L. Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. Eur Urol. 2007 Mar;51(3):605-13; discussion 613
  • Maffezzini M, Campodonico F, Canepa G, Capponi G, Fontana V. Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder. Eur Urol. 2007 Apr; 51(4): 956-61
  • Maffezzini M. TC incidence increasing: spread the word. Eur Urol. 2007 Mar;51(3):596-7


  • Maffezzini M, Campodonico F, Canepa G, Capponi G, Fontana V.
    Short-Schedule Intravesical Gemcitabine With Ablative Intent in Recurrent Ta-T1, G1-G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder. Eur Urol. 2006 Sep 20
  • Maffezzini M. TC Incidence Increasing: Spread the Word. Eur Urol. 2006 Aug 28
  • Maffezzini M, Gerbi G, Campodonico F, Parodi D. A multimodal perioperative plan for radical cystectomy and urinary intestinal diversion: effects, limits and complications of early artificial nutrition.
    J Urol. 2006 Sep;176(3):945-8; discussion 948-9
  • Maffezzini M. Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77. Eur Urol. 2006 Sep;50(3):623-4; author reply 624-5. Epub 2006 May 4
  • Maffezzini M, Campodonico F. Some remarks on a re-do urinary diversion by converting the ileal conduit to an Indiana pouch. Arch Ital Urol Androl. 2006 Jun;78(2):64-6
  • Maffezzini M, Campodonico F, Capponi G, Canepa G, Gavazzi L, Calcagno T. Results and complications with the mini-laparotomic incision in 52 consecutive radical retropubic prostatectomies. Arch Ital Urol Androl. 2006 Jun;78(2):61-3
  • Campodonico F, Casarico A, Gavazzi L, Calcagno T, Capponi G, Canepa G, Bandelloni R, Maffezzini M. Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsy. Arch Ital Urol Androl. 2006 Jun;78(2):39


  • Campodonico F, Canepa G, Capponi G, Bozzo L, Maffezzini M. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability. Anticancer Res. 2005 May-Jun;25(3c):2381-4
  • Maffezzini M, Gavazzi L, Calcagno T, Capponi G, Bandelloni R. Still a place for the classical systematic sextant technique? Cancer detection rates and complications in 1025 consecutive prostatic biopsies. Arch Ital Urol Androl. 2005 Jun;77(2):106-8
  • Campodonico F, Bandelloni R, Maffezzini M. Paraganglioma of the prostate in a young adult. Urology. 2005 Sep;66(3):657
  • Maffezzini M. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2005 Sep;174(3):1151-2


  • Hurle R, Poma R, Maffezzini M, Manzetti A, Piccinelli A, Taverna G, Bellavita P, Graziotti P. A simple mathematical approach to calculate blood loss in radical prostatectomy. Urol Int. 2004;72(2):135-9
  • Campodonico F, Benelli R, Michelazzi A, Ognio E, Toncini C, Maffezzini M. Bladder cell culture on small intestinal submucosa as bioscaffold: experimental study on engineered urothelial grafts. Eur Urol. 2004 Oct; 46(4):531-7
  • Maffezzini M, Gerbi G, Campodonico F, Parodi D, Capponi G, Spina A, Guerrieri AM. Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderly. Surg Oncol. 2004 Dec;13(4):197-200
Azioni sul documento